Due to their broad differentiation potential and their persistence into adulthood, human neural crest-derived stem cells (NCSCs) harbour great potential for autologous cellular therapies, which include the treatment of neurodegenerative diseases and replacement of complex tissues containing various cell types, as in the case of musculoskeletal injuries. The use of serum-free approaches often results in insuffi cient proliferation of stem cells and foetal calf serum implicates the use of xenogenic medium components. Thus, there is much need for alternative cultivation strategies. In this study we describe for the fi rst time a novel, human blood plasma based semi-solid medium for cultivation of human NCSCs. We cultivated human neural crest-derived inferior turbinate stem cells (ITSCs) within a blood plasma matrix, where they revealed higher proliferation rates compared to a standard serum-free approach. Three-dimensionality of the matrix was investigated using helium ion microscopy. ITSCs grew within the matrix as revealed by laser scanning microscopy. Genetic stability and maintenance of stemness characteristics were assured in 3D cultivated ITSCs, as demonstrated by unchanged expression profi le and the capability for self-renewal. ITSCs pre-cultivated in the 3D matrix differentiated effi ciently into ectodermal and mesodermal cell types, particularly including osteogenic cell types. Furthermore, ITSCs cultivated as described here could be easily infected with lentiviruses directly in substrate for potential tracing or gene therapeutic approaches. Taken together, the use of human blood plasma as an additive for a completely defi ned medium points towards a personalisable and autologous cultivation of human neural crest-derived stem cells under clinical grade conditions.
Introduction
With regards to their regenerative capability and easy accessibility, adult stem cells (ASCs) are promising candidates for medical applications (Toma et al., 2002; Beltrami et al., 2003; Mezey et al., 2003; Meza-Zepeda et al., 2008) . Furthermore, ASCs enable autologous therapies, avoiding the need of long-term immunosuppression in patients (Gimble and Guilak, 2003) .
Amongst other goals, stem cell-based regenerative medicine focuses on the future treatment of neurodegenerative disorders (Lindvall and Kokaia, 2010) , craniofacial tissue regeneration, skin replacement therapy (Seo et al., 2004; Bluteau et al., 2008; Bulgin et al., 2011) and regeneration of bone defects (Seebach et al., 2010) .
However, stem cell products without in vitro cultivation contain, in general, only low numbers of stem cells. Thus, their therapeutic effect is often limited, making an in vitro expansion-step crucial for clinical application of stem cells. Remarkably, long-term cultivation of mammalian stem cells is often associated with genetic instabilities due to cultivation conditions and the extraction from their three-dimensional endogenous niche (Izadpanah et al., 2008; Bork et al., 2010) . As a consequence, stem cells may escape their growth regulation resulting in tumour formation (Tolar et al., 2007; Widera et al., 2008; Rosland et al., 2009; Kaus et al., 2010) . Therefore, optimal culture conditions need to enable high proliferation rates in order to minimise the time of cell cultivation in vitro. As recommended by the Food and Drug Administration (FDA), the cultivation time of human stem cells for transplantation purposes should not exceed fi ve weeks (Fink, 2009) . Although very promising, animal serum-free approaches often provide only limited proliferation of the isolated stem cells, making their use in clinical praxis problematic (Mannello and Tonti, 2007) .
In addition to the possibly short cultivation time, the stemness characteristics and unchanged differentiation potential of the cells have to be maintained.
Regarding these challenges, a medium comprising foetal calf serum (FCS) is preferentially used for cultivating adult human stem cells (Bryan et al., 2011) . FCS contains important supplements such as growth factors and assures optimal growth and cellular viability (Bieback et al., 2009; Bryan et al., 2011) . However, the use of FCS for human stem cell culture is associated with remarkable diffi culties. Due to differences between donor animals, batch variations may affect experimental reproducibility (Honn et al., 1975) . Furthermore, the availability of FCS is limited. Additionally, there are several cautionary notes concerning the transplantation of human stem cells cultivated with FCS. Due to its bovine origin, there is a residual risk of transmitting infectious agents (Heiskanen et al., 2007) such as animal-borne pathogens (Erickson et al., 1991; Zabal et al., 2000) . Moreover, transplantation of autologous cells exposed to FCS can cause immune response reactions in the human body (Tuschong et al., 2002; Sundin et al., 2007) .
EFFICIENT ANIMAL-SERUM FREE 3D CULTIVATION METHOD FOR ADULT HUMAN NEURAL CREST-DERIVED STEM CELL THERAPEUTICS J.FW Greiner et al. Animal serum-free 3D cultivation method for NCSCs
Being the liquid component of human blood, blood plasma is an easily accessible and economical additive for human cell cultivation. As one of the most important ingredients of blood plasma, fi brinogen plays a crucial role in the clotting of blood after an injury (Fig. 1) .
Fibrin polymers are of great interest for both human cell culture and medicine. Up to now, fi brin polymers are already used for clinical applications, for instance as fi brin patches, fi brin glue and adhesives in skin transplantation (Dahlstrom et al., 1992; Currie et al., 2001; Modi and Rahamim, 2005) .
Importantly, the use of fi brin as medium supplement offers the opportunity to cultivate human cells in a threedimensional matrix, which mimics more closely the endogenous niche than does conventional two-dimensional culture. Such cultivation also offers the advantage that the cells can be directly transplanted into tissue of interest without removal from the matrix. Using fibrinogen activated by thrombin, Ronfard et al. cultivated human keratinocytes, which were subsequently transplanted into burn wounds (Ronfard et al., 1991) . In addition, the use of fi brin seems to provide a further benefi t for the survival of in vitro cultivated cells. In this context, Acevedo et al. recently showed that senescent cultures of human dermal fi broblasts can re-enter the cell cycle if immobilised in a fi brin polymer (Acevedo et al., 2009) . Moreover, the use of fi brin improves the in vivo survival of transplanted human myoblasts (Gerard et al., 2011) . However, if fi brin is applied as artifi cial supplement for conventional cultivation medium, there is still need for additional FCS.
In the present study, we used human blood plasma as a replacement for FCS and at the same time as a source of 3D matrix forming fi brin. We cultivated multipotent neural crest-derived inferior turbinate stem cells (ITSCs) (Hauser et al., 2011) under serum-free control conditions and within 3D blood plasma matrix. Due to their potential to differentiate effi ciently not only in neural lineages, but also to build up mesodermal cell types they are ideal candidates for clinical approaches focusing on replacement of complex tissues as in the case of craniofacial injuries, which require regeneration of nerves, bones and muscular tissue. We show that ITSCs grown within the three-dimensional blood plasma matrix proliferate faster than under control conditions without changes in their ploidity level, selfrenewal-capability or expression profi le. Furthermore, even if pre-cultivated within the 3D matrix, ITSCs still harbour their differentiation potency as demonstrated by effi cient differentiation into neuronal and osteogenic cell types. Finally, ITSCs can be virally transduced within the matrix making the cultivation method presented here suitable for gene therapeutic approaches.
Materials and Methods

Source material and tissue preparation
Human nasal inferior turbinates were obtained by biopsy during routine nasal surgery, after informed consent according to local and international guidelines (Bezirksregierung Detmold/Münster). After an initial enzymatic dissociation step using Dispase II (SigmaAldrich, Taufkirchen, Germany; 0.55 U/mg) at 4 °C for at least 12 h, the tissue was mechanically disintegrated using the McIlwain Tissue Chopper followed by dissociation with Collagenase NB4 (1.17 U/mL; SERVA Electrophoresis, Heidelberg, Germany) for 1.5 h at 37 °C.
Cultivation of ITSCs as free-fl oating spheres
After initial mechanical disintegration and enzymatic dissociation, ITSCs were pre-cultivated in a humidifi ed incubator (Binder, Tuttlingen, Germany) for 96 h at 37 °C, 5 % O 2 and 5 % CO 2 in Dulbecco´s modifi ed Eagle´s medium/Ham´s F-12 (1:1) (DMEM/F-12; Biochrom, Berlin, Germany) with addition of 200 mM L-Glutamin (L-Glu, Sigma-Aldrich), epidermal growth factor (EGF; 20 ng/mL; R&D Systems, Wiesbaden, Germany), basic fi broblast growth factor (bFGF/FGF-2; 40 ng/mL; labmade) and B27 supplement (Chen et al., 2008) in low adhesion T25 tissue culture flasks (Greiner Bio-One, Frickenhausen, Germany). Hereinafter, the described composition of medium is referred to as "standard medium". The lab-made compounds of the standard medium were tested for ITSCs and mouse NSCs in terms of proliferation and morphology, resulting in no signifi cant differences when commercial FGF-2 (Miltenyi Biotec, Bergisch Gladbach, Germany) and B27 (Invitrogen/Life Technologies, Darmstadt, Germany) were used instead of the lab-made compounds (data not shown). "Pre-culture" refers to an initial priming step, which includes the isolation of ITSCs out of the dissected tissue by medium supporting survival of stem cells until primary neurosphere formation was observed. Thereafter, ITSCs were cultivated in standard medium with additional heparin (0.5 U/mL, Sigma-Aldrich) or 3D blood plasma matrix (see below). Cultivation took place at 37 °C, 5 % O 2 and 5 % CO 2 with medium change every two days and passage after at least 7 days.
Cultivation of ITSCs using human blood plasma derived 3D matrix Clinically accredited therapeutic human blood plasma (BP) was obtained from Institut für Laboratoriums-und Transfusionsmedizin (Bad Oeynhausen, Germany) and stored at -80 °C until use. For culture of ITSCs within the 3D blood plasma matrix, ITSCs growing as free-fl oating spheres (see above) were harvested by centrifugation at 300 g and dissociated using pre-warmed Accutase (PAA, Pasching, Austria) for 30 min. ITSC-suspension was re-suspended in standard medium followed by J. FW Greiner et al. Animal serum-free 3D cultivation method for NCSCs supplementation with 10 % BP and immediately placed into appropriate cell culture dishes. The supplementation of standard medium with BP led to rapid formation of a 3D matrix, which immobilised the cells. The ITSCs within the matrix were further cultivated at 37 °C, 5 % O 2 and 5 % CO 2 . For passaging, ITSCs were removed from the matrix using Collagenase I (SERVA Electrophoresis) for 1 h at 37 °C on an orbital shaker (Edmund Bühler, Hechingen, Germany) followed by harvesting by centrifugation at 300 g.
Scanning electron microscopy of the 3D blood plasma matrix Addition of 10 % human blood plasma to standard medium led to formation of a 3D fi brin matrix. Matrix was briefl y washed with phosphate buffer followed by fi xation in 4 % glutaraldehyde and 2 % paraformaldehyde (PFA) in phosphate buffer for 2 h. After washing four times for 2 min at room temperature (RT) in phosphate buffered saline (PBS) (1x), matrix was post-fi xed in the dark using 2 % osmium tetroxide, 1.5 % potassium hexacyanoferrate in phosphate buffer, pH 7.2. Dehydration of samples was done in an ascending acetone series and by subsequent critical point-drying. Analysis was performed using a scanning electron microscope (Zeiss LEO1530, Carl Zeiss, Jena, Germany).
Helium ion microscopy
After formation of the fi brin matrix, fi xation was performed in phosphate buffer using 4 % PFA and 10 % glutaraldehyde with addition of picric acid (15 μL / 30 mL PBS). After fixation, the matrix was washed with PBS (1x) and postfi xed in osmium tetroxide for 2 h. The second washing step (1x PBS) was followed by incubation in 70 % ethanol for 1 h. Afterwards, the postfi xed fi brin matrix was washed three times with PBS (1x). Critical point-drying was subsequently performed in 100 % acetone. Analysis was performed using a helium-ion-microscope (Zeiss ORION, Carl Zeiss 
Proliferation assay of cultivated ITSCs
A defi ned number of ITSCs, previously cultivated as free-fl oating spheres, were cultivated in standard medium supplemented with heparin or 10 % BP for 5 days. Cell numbers were determined after trypsinisation (Trypsin-EDTA, 0.5 mg/mL; PAA) of cultivated cells for 15 min at 37 °C, followed by cell number determination using the Cellometer Auto T4 device (Peqlab Biotechnology, Erlangen, Germany). Statistical analysis of cell proliferation was done using Graph Pad Prism (GraphPad Software, La Jolla, CA, USA).
Flow cytometric measurement of DNA content DNA content of 1x10 6 ITSCs cultivated in BP matrix and ITSCs grown as free-fl oating spheres was determined using CyStain PI absolute T-Kit (PARTEC, Münster, Germany) and acquisition with the CyFlow space fl ow cytometer (PARTEC) according to manufacturers guidelines. The analysis was processed with the FloJo software (Tree Star, Ashland, OR, USA). Doublet discrimination was done by gating using FL3-A vs. FL3-W signals as recommended in (Nunez, 2001 ).
Limited dilution assay
To analyse the clonal effi ciency of tertiary ITSCs, a limited dilution assay was performed as described in (Widera et al., 2009 ) and cultivated in standard medium and standard medium containing 10 % BP. Clones were analysed over the time period of 2 weeks.
Additionally, 3D-precultivated tertiary ITSCs clones were plated at clonal density and cultivated in DMEM (Sigma-Aldrich) containing 10 % FCS (Sigma-Aldrich, lot: 126K3398) followed by cultivation at 37 °C, 5 % CO 2 and atmospheric O 2 in a humidifi ed incubator for 14 days. To identify multi-lineage differentiation of single cell clones immunocytochemical analyses were performed (see Immunocytochemistry).
Fig. 1. Coagulation cascade of proteins in the human body.
Fibrinogen is converted by thrombin and factor XIIIa to a cross-linked fi brin polymer (Currie et al., 2001; Santacroce et al., 2006) .
J.FW Greiner et al. Animal serum-free 3D cultivation method for NCSCs
Reverse transcription PCR For RNA isolation cells from three different donors were cultivated both within the 3D BP matrix and as freefl oating spheres. Total RNA was isolated using RNeasy Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer's guidelines. Quality and concentration of isolated RNA was subsequently investigated by Nanodrop UV spectrophotometry. Afterwards cDNA was synthesised using First Strand cDNA Synthesis Kit (Fermentas, St. Leon-Rot, Germany). PCR was performed hereinafter using KAPA2G Robust PCR Kit (Peqlab Biotechnology GmbH, Erlangen, Germany). For primer sequences (0.5 μM, Metabion, Martinsried, Germany) see Table 1 .
Immunocytochemistry
For immunocytochemistry ITSCs were cultivated within 3D BP matrix. Fixation was performed using phosphate buffered 4 % PFA followed by three washing steps with PBS (1x). Afterwards, cells were permeabilised with 0.02 % Triton X-100 for 30 min at RT and blocked using 5 % of appropriate normal serum followed by addition of the primary antibody for 2 h at RT. Used antibodies were anti β-III-tubulin 1:300 (New England Biolabs, Frankfurt am Main, Germany), anti smooth muscle actin 1:50 (αSMA; Sigma-Aldrich), anti-vimentin (Developmental Studies Hybridoma Bank, Iowa City, IA, USA), anti human nestin 1:100 (Millipore, Billerica, MA, USA), anti S100 1:100 (Dako, Hamburg, Germany) and anti NF-H (Sigma-Aldrich). The secondary fl uorochrome-conjugated antibodies were diluted 1:300 (goat anti mouse conjugated with Alexa 555 or goat anti rabbit Alexa 555; Molecular Probes, Göttingen, Germany) and incubated for 1 h at RT. After RNase treatment (>500 U/mL, Fermentas) to avoid signal caused by RNA, the nuclear counterstaining was performed with SYTOX green (1:20,000, Molecular Probes, Göttingen, Germany). Fluorescence imaging was performed using confocal laser scanning microscopy (LSM 510, Carl Zeiss).
Real-time PCR
All qPCR reactions were performed as triplicate using Platinum SYBR Green qPCR Super-Mix UDG (Invitrogen, Life Technologies GmbH, Darmstadt, Germany) according to the manufacturers guidelines and assayed with a Rotor Gene 6000 (QIAGEN, Hilden, Germany).
Neuronal differentiation
For neuronal differentiation of ITSCs, cells of three donors pre-cultivated within the 3D BP matrix were removed from the matrix as described above, harvested by centrifugation at 300 g, resuspended in DMEM (Sigma-Aldrich) containing 10 % FCS (Sigma-Aldrich, lot: 126K3398) an plated at a density of 5x10 4 cells per 12 wells followed by cultivation at 37 °C, 5 % CO 2 and atmospheric O 2 in a humidifi ed incubator. After 48 h, 1 μM dexamethasone (Sigma-Aldrich), 2 μM insulin (Sigma-Aldrich), 500 μM 3-isobutyl-1-methylxanthine (Sigma-Aldrich), 200 μM indomethacin (Sigma-Aldrich) and 200 μM ethanol were added to the medium to induce neuronal differentiation (neuronal induction medium). As control, undifferentiated neurospheres were used. Neuronal differentiation occurred for 1 month followed by immunocytochemical staining and PCR analysis. The function of mature ITSCs was analysed by synaptic vesicle recycling. 
Osteogenic differentiation
For forced osteogenic differentiation of ITSCs, cells of three donors pre-cultivated within the 3D BP matrix were removed from the matrix as described above, harvested by centrifugation at 300 g and resuspended in DMEM (Sigma-Aldrich) containing 10 % FCS (Sigma-Aldrich, lot: 126K3398) followed by cultivation at densitiy of 3x10 3 /cm 2 , 37 °C, 5 % CO 2 and atmospheric O 2 in a humidifi ed incubator. After 48 h, 100 nM dexamethasone (Sigma-Aldrich), 10 mM β-glycerophosphate (SigmaAldrich) and 0.05 mM L-ascorbic acid-2-phosphate (Sigma-Aldrich) were added to the medium to induce osteogenic differentiation (osteogenic induction medium). As control, cells were cultivated using DMEM (SigmaAldrich) supplemented with 10 % FCS (Sigma-Aldrich, lot: 126K3398) without additional supplements. The ITSCs were differentiated for 12 days (for alkaline phosphatase (ALP) activity assay) or for 18 days for histochemical stainings and the PCR analysis.
Detection of alkaline phosphatase activity
The ALP activity was measured in ITSCs differentiated for 12 days in osteogenic induction medium using the Alkaline Phosphatase Detection Kit (Millipore) according to the manufacturer's guidelines.
Histochemical staining for the detection of osteogenic differentiation
ITSCs differentiated for 18 days in osteogenic induction medium were fi xed for 15 min using 4 % PFA followed by wash steps using PBS (1x) for Alizarin Red S staining or with ddH 2 O for Von Kossa staining. For Alizarin Red S staining, the staining solution (1 % Alizarin Red in ddH 2 O, Waldeck, Münster, Germany) was applied for 5 min at RT followed by imaging using the AMG EVOS xl microscope (PeqLab Biotechnology). For Von Kossa staining, ddH 2 O containing 5 % silver nitrate (Fluka Chemie, Buchs, Switzerland) was applied for 60 min under UV light followed by washing with ddH 2 O. Afterwards, ITSCs were incubated in 5 % sodium thiosulphate solution (in ddH 2 O, Fluka Chemie) for 3 min and washed using ddH 2 O. Kernechtrot-solution containing 100 mL ddH 2 O, 5 g aluminium sulphate and 0.1 % Kernechtrot (Merck, Darmstadt, Germany) was applied for 5 min followed by washing with 100 % ethanol and two times with 96 % ethanol. Imaging was performed as described for Alizarin Red Staining.
Stable lentiviral transduction of ITSCs
ITSCs negatively tested for HIV, HCV and HBV were infected with lentivirus pFUGW containing a constitutively
5 ITSCs were cultivated within 3D BP matrix within 12-well culture plates. After thawing a high-titer virus suspension, followed by centrifugation, the pelleted virus was dehumidifi ed. After resuspension in standard medium, 200 μL of the virus-suspension was placed together with 1.8 mL standard medium on top of ITSCs in the matrix. In addition, 20 μL chloroquine was added to the suspension. After viral transfection, ITSCs were cultivated as described above.
Results
3D blood plasma matrix consists of dense meshwork with pores of different size
First, we investigated the ultrastructural appearance of the 3D blood plasma matrix formed after supplementation of standard medium with 10 % human blood plasma. As demonstrated by scanning electron microscopy (SEM), the surface of the matrix consisted of dense meshwork of fi brin polymer ( Fig. 2A, upper panel) . Blow up image revealed dense network of fi brin fi bres. Due to the goldcoating no exact determination of the fi bre-diameter was possible. Recently, helium ion microscopy (HIM) became commercially available. This technique offers several advantages compared to conventional electron microscopy. Due to the short De Broglie wavelength of the helium ions and the small He source size, an edge resolution of up to 0.25 nm can be achieved. Using combined helium and electron beams, the HIM also provides charge compensation so that non-conducting samples can be imaged without specimen coating. The three-dimensional structure of the matrix was investigated using HIM. In addition to the meshwork-like surface structure, HIM highresolution analysis revealed the presence of intermediate spaces in all three dimensions of the matrix ( Fig. 2A, lower  panel) . The presence of pores of different size suggested that the 3D BP matrix may have a biocompatibility with cultivated cells.
Fibrin nanofi bres have a mean diameter of approximately 50 nm
Using HIM we investigated the diameter of fi brin fi bres within the 3D BP matrix. High resolution magnifi cation imaging revealed heterogeneous diameter of nanofi bres with an average diameter of 49.1 ±22.6 nm (Fig. 2B) .
ITSCs survive within the matrix and are able to form secondary neurospheres A schematic view of the cultivation is shown in Fig. 3A . ITSCs pre-cultivated as spheres (Fig. 3A , left image) were dissociated and afterwards passaged into standard medium supplemented with 10 % human blood plasma leading to formation of a dense 3D matrix. Under these conditions cells grew homogenously distributed and showed spiny and long shaped cell bodies (Fig. 3A, right image) . Importantly, after the cultivation step within the matrix they kept the ability to form secondary spheres (data not shown).
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Human ITSCs grow three-dimensionally within the BP matrix In order to investigate the distribution of ITSCs within the matrix in the Z-dimension, a microscopical analysis using bright fi eld imaging followed by Z-sectioning and 3D reconstruction (Keyence BZ 8000 microscope, Keyence Corp, Osaka, Japan) was initially performed (data not shown). Due to the high optical density of the matrix, which interfered with the tracking of ITSCs in substrate using fi eld bright microscopy, ITSCs were transfected transiently with a GFP-expression vector and processed for imaging using confocal laser scanning microscopy. As shown in Fig. 3B (left image), more than 90 % of ITSCs showed a robust expression of GFP. In order to investigate the localisation of GFP-positive ITSCs within the fi brin matrix, GFPsignals were analysed by optical sectioning (Z-stack) with subsequent 3D reconstruction. GFP-positive ITSCs were distributed homogenously not only on the X-and Y-axis 
but also in the third dimension on the Z-axis (Fig. 3B , right image) revealing three dimensional growth of the cells within the substrate.
Three dimensional culture of ITSCs within 3D BP matrix leads to increased proliferation
ITSCs were cultivated as spheres or as 3D culture with addition of human blood plasma. Cell numbers of ITSCpopulations from three donors were determined over a defi ned period of time. Under 3D conditions ITSCs proliferated signifi cantly faster than under sphere culture conditions with an average doubling time of 25.0 h, in contrast to sphere ITSCs, which doubled within 175 h (Fig. 4A ).
Highly proliferative ITSCs remained genetically stable
Since fast proliferation of cells may lead to changes of ploidy, the DNA content of ITSCs was investigated under both culture conditions using PI staining and subsequent
Fig. 3. ITSC-cultivation and localisation of ITSCs within the fi brin matrix. (A) Schematic view of ITSC-cultivation
in the 3D blood plasma matrix. After dissociation of the conventionally cultivated spheres (left microscopical picture), ITSCs were expanded as 3D culture in the matrix (right image). Under these conditions ITSCs grew homogenously distributed and showed spiny and long shaped cell bodies. After the expansion step, ITSCs were able to form secondary spheres. (B) ITSCs grow three dimensionally and not only on the top or at the bottom of the matrix. ITSCs were transiently transfected with GFP and subsequently cultivated within 3D blood plasma matrix. Z-sectioning using confocal microscopy and 3D reconstruction revealed three dimensional growth of the cells.
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fl ow cytometric analysis. After three months of in vitro culture, ITSCs cultivated under 3D conditions and as spheres revealed a typical DNA content for diploid cells (Fig. 4B) without signs of polyploidy as demonstrated by the absence of PI signal above the G 2 /M peak. Remarkably, ITSCs cultivated under 3D conditions showed largely increased signal for mitotic cells (G 2 /M) compared to the sphere approach. In addition, an increase of the sub G1 peak was observed after cultivation within the matrix.
3D cultivation does not impair clonal effi ciency and self-renewal of ITSCs
To investigate potential impact of the 3D cultivation on the stemness characteristics of ITSCs, we investigated clonal effi ciency in the third generation of clonal growth. After limiting dilution, ITSCs pre-cultivated within the 3D matrix were further cultivated as neurospheres or within the blood plasma matrix. After microscopical investigation, clonally grown ITCS-spheres or colonies (secondary spheres or colonies) were dissociated and a further limiting dilution step was applied until formation of tertiary neurospheres or colonies. 38.51 ±11.4 % of tertiary ITSC-clones kept their ability to form quaternary neurospheres in appropriate medium (Fig. 4C ). In addition, tertiary ITSC-clones further cultivated in the 3D matrix displayed a clonal effi ciency of 35.87 ±2.4 %. Importantly, tertiary single-cell clones previously cultivated in the 3D matrix were able to perform multilineage differentiation into β-III-tubulin-and αSMA-or Vimentin-positive cells at clonal density, when exposed to medium comprising FCS (Fig. 4D) . Remarkably, precisely one tertiary ITSC cell gave rise to several further differentiated cells expressing mesodermal and neuro-ectodermal markers. Taking under consideration Animal serum-free 3D cultivation method for NCSCs the unaffected clonal effi ciency of even tertiary clones, we demonstrate that 3D-cultivated ITSCs retain their capability of self-renewal.
3D cultivated ITSCs show unchanged expression pattern
In order to determine whether the expression of stemness and neural crest markers were infl uenced by culture in presence of human blood plasma, expression profi les of ITSCs were investigated by immunocytochemistry (ICC) and reverse transcription PCR. For ICC, ITSCs were fi xed and stained against nestin and S100 as described in Materials and Methods. Demonstrably, ITSCs showed strong expression of nestin and S100 at protein level as demonstrated by strong signal for both marker proteins (Fig. 5A) . For the PCR analysis, RNA was isolated and analysed from ITSC-populations of three donors previously cultivated under 3D conditions or as freefl oating spheres (Fig. 5B) . The message for neural crest markers Twist, Slug, Sox9, and for CD117 was clearly detected in ITSCs cultivated under both conditions. In addition, the expression of ABCG2 was detected in 3D 
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and sphere cultures. Sox9 and ABCG2 showed slightly different expression levels depending on culture conditions. Furthermore, high level of CNPase-expression was detected in both approaches, which is a typical hallmark of ITSCs (Hauser et al., 2011) . In order to investigate the expression of pluripotency-associated markers, reverse transcription PCR for the c-Myc message and real-time PCR for Oct4, Sox2 and WDR5 was performed. c-Myc was expressed in 3D cultures at nearly the same level than in neurosphere cultures. In addition, real-time PCR revealed no signifi cant changes of the expression of Oct4, Sox2 and WDR5 resulting from the 3D-cultivation. Importantly, in both approaches these markers were expressed at lower level than in ES cell like NTERA-2, which is a typical hallmark of adult human neural crest-derived stem cells (Clewes et al., 2011; Hauser et al., 2011) (Fig. 5C ). Remarkably, Klf4 was expressed at signifi cantly higher level in ITSCs cultivated within the 3D matrix.
Cultivation within the 3D blood plasma matrix does not affect the potential of ITSCs to perform differentiation into ectodermal lineage
Ectodermal differentiation potential of 3D-cultivated ITSCs was investigated by performing a directed differentiation assay for 1 month, followed by analysis of the differentiated ITSCs using ICC, PCR as well as synaptic vesicle recycling (Fig. 6A) . As shown by ICC, differentiated ITSCs showed neuronal morphology accompanied by strong co-expression of β-III-tubulin and Neurofi lament-H at protein level (Fig. 6B) . Furthermore, strong expression of β-III-tubulin and Synaptophysin was detectable by means of PCR in differentiated ITSCs (Fig.  6C) . In contrast, undifferentiated ITSCs cultivated as neurospheres revealed no expression of Synaptophysin and only very low expression level of β-III-tubulin. In order to determine the ability of neuronally differentiated ITSCs to perform vesicle recycling, FM 1-43 labelling was achieved. ITSCs differentiated into osteogenic lineage show ALP activity and Ca 2+ deposition. ALP activity as a marker of early osteoblast-like cells was measured after 12 days of osteogenic differentiation. As demonstrated by strong ALP signal and absence of activity in the control (left panel), ITSCs pre-cultivated within the 3D matrix still be able to perform osteogenesis. Additionally, as a late marker of osteoblastic differentiation, the mineralisation was investigated after 18 days of culture in osteogenic medium. The mineralisation was visualised by Alizarin Red S stained Ca 2+ deposition within the cells only found in cells cultivated in osteogenic medium and not in the control (middle panel). Von Kossa staining revealed a clear signal of Ca 2+ (black) in the differentiated ITSCs (cytoplasma: pink, cell nuclei: red), whereas no mineralisation was observable in the control (right panel). (B) ITSCs differentiated in osteogenic lineage express characteristic transcripts. After 18 days, differentiated ITSCs showed downregulation of stemness marker nestin, while strong expression of osteogenic markers osteopontin and osteocalcin was detectable by reverse transcription PCR. (C) Osteoblast-like cells showing ALP activity expressed αSMA. The detection of ALP activity was followed by immunocytochemical staining for αSMA. ITSCs showing ALP activity were positive for αSMA, whereas ITSCs lacking ALP activity showed no staining.
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After stimulation with 75 mM KCl, a strong labelling with FM 1-43 was observed in differentiated ITSCs suggesting functional synaptic vesicle recycling. In contrast, no signal was detectable in undifferentiated ITSCs growing as neurospheres, which were used as controls (Fig. 6D ).
ITSCs cultivated within the matrix harbour osteogenic differentiation potential as indicated by ALP activity and mineralisation
As a marker of osteogenesis, ALP activity was measured after 12 days of osteogenic differentiation. As demonstrated by strong ALP signal and absence of activity in the control (Fig. 7A , left panel), ITSCs cultivated within the 3D matrix are able to perform osteogenesis. In addition to the ALP activity, as a late marker of osteoblastic differentiation, the mineralisation was investigated after 18 days of culture in osteogenic medium. The mineralisation of differentiated ITSCs was visualised by Alizarin Red S stained Ca 2+ deposition within the cells, which was found in cells cultivated in osteogenic medium and rarely in single cells in the control approach, suggesting spontaneous predifferentiation in osteogenic direction of at least some cells (Fig. 7A, middle panel) . As a further proof of osteogenic differentiation, after 18 days of cultivation in osteogenic medium, Von Kossa staining was performed to visualise the mineralisation. A clear signal was observed only in the differentiated ITSCs, whereas no mineralisation was observable in the control (Fig. 7A, right panel) .
ITSCs differentiated in osteogenic lineage express characteristic transcripts
In order to determine expression of characteristic osteogenic markers in differentiated ITSCs, expression profi les were investigated by reverse transcription PCR (Fig. 7B) . After 18 days, differentiated ITSCs showed downregulation of stemness marker nestin, while strong expression of osteogenic markers osteopontin and osteocalcin was detectable. Low expression level of osteopontin was detected already in FCS-cultivated control ITSCs suggesting spontaneous pre-differentiation in osteogenic direction of at least some cells. In contrast, ITSCs cultivated under control conditions kept their strong expression of nestin, suggesting that majority of the cells kept their stemness.
Osteoblast-like cells showing ALP activity express αSMA
Active human osteoblasts are characterised by simultaneously detectable ALP activity and expression of αSMA (Kinner and Spector, 2002) . Therefore, the detection of ALP activity was followed by immunocytochemical staining for αSMA in ITSCs subjected to osteogenic differentiation for 13 days. Here we demonstrated that cells showing ALP activity were positive for αSMA (Fig. 7C) . Demonstrably, cells lacking ALP activity showed also no positive staining for αSMA.
ITSCs can be lentivirally transduced within the 3D blood plasma matrix For insertion of genes into mammalian cells, lentiviral transduction provides the advantage that it ensures stable genomic integration. However, lentiviral infection of suspension cells is highly challenging and ineffi cient, particularly when cells are cultivated as free-fl oating spheres (Holm Zaehres, MPI Münster, personal communication) .
ITSCs cultivated with addition of human blood plasma were lentivirally transduced with a pFUGW lentivirus, harbouring GFP under the constitutive human ubiquitin promoter. Transduction of ITSCs was performed directly in substrate without removing the cells from the 3D matrix resulting in high amount of GFP positive cells, as demonstrated by confocal microscopy (Fig. 8A ) and fl ow cytometry (72.6 %, Fig. 8B ). Importantly, transduced ITSCs were able to form secondary spheres with stable GFP-expression (Fig. 8C) . 
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Discussion
This study describes for the first time a novel semisolid animal serum-free medium for 3D cultivation of human neural crest-derived stem cells. 3D-cultivated ITSCs revealed higher proliferation rates compared to standard medium. Moreover, ITSCs remained genetically stable and kept their stemness characteristics, such as their characteristic expression profile and capability for self-renewal and directed mesodermal and ectodermal differentiation in vitro. Importantly, a directed differentiation into osteogenic cell types underlined their remaining high potential for musculoskeletal tissue regeneration. In addition, lentiviral transfection could be performed directly in substrate. Highly multipotent neural crest-derived stem cells can be derived from various sources, such as skin, palate, oral mucosa or dental pulp as well as olfactory and respiratory mucosa (Franssen et al., 2007; Stevens et al., 2008; Widera et al., 2009; Davies et al., 2010; Clewes et al., 2011; Hauser et al., 2011) . Taken together, NCSCs display the common characteristic to be expandable in vitro as free-fl oating spheres, while expressing high levels of the intermediate fi lament nestin. Moreover, NCSCs are known to effi ciently undergo neural crest typical differentiation pathways, e.g., into osteogenic and neuronal cells (Sieber-Blum and Grim, 2004; Widera et al., 2007; Hunt et al., 2008; Delorme et al., 2010; Clewes et al., 2011) . Concerning the expression of pluripotency markers, human trunk EPI-NCSCs displayed similar expression levels of Klf4 and c-Myc, when compared to the embryonic stem cell line H9 (Clewes et al., 2011) . In contrast, Oct4 and Sox2 showed pronounced differences. In our study, ITSCs revealed expression of pluripotency-associated markers c-Myc, Oct4, Sox2 and WDR5 both in 3D and neurosphere cultures, while Klf4 was expressed at signifi cantly higher level in 3D-cultivated ITSCs. In many cases Klf4 is acting as an inhibitor of proliferation (Sur, 2009) but in some cases such as T-cell development Klf4 can regulate a pro-mitotic activity . Similar to T-cell proliferation, highly proliferating ITSCs show a high level of Klf4 expression suggesting a functional correlation of ITSC proliferation via Klf4 expression.
With regard to stem cell-based approaches for treatment of injured complex tissues, high amounts of stem cells are needed for effective transplantation. However, most adult niches possess only very low amounts of stem cells. Thus, isolated stem cells need to be expanded in vitro before transplantation (Sotiropoulou et al., 2006) . Although several approaches exist to cultivate stem cells in a defi ned, serum-free medium (see (Mannello and Tonti, 2007) for review), the proliferation rates under such conditions seem to be generally lower than in medium containing FCS. Since the use of FCS for therapeutic approaches underlies practical limitations and severe health risks (Honn et al., 1975; Mannello and Tonti, 2007; Chachques et al., 2004; Dimarakis and Levicar, 2006; Erickson et al., 1991 Animal serum-free 3D cultivation method for NCSCs Sundin et al., 2007; Zabal et al., 2000) , this study focused on the establishment of a novel, personalisable, animal serum-free medium for cultivation of human neural crestderived ITSCs based on human blood plasma as a potential replacement for FCS. It is well-known that medium supplemented with human serum promotes expansion of human mesenchymal stem cells as well as human hematopoietic progenitor cells in vitro (Oreffo et al., 1997; Yamaguchi et al., 2002; Walenda et al., 2011) . However, rapid senescence and arrested cell growth of MSCs were also displayed by several studies as a consequence of exposure to human serum supplemented medium (Kuznetsov et al., 2000; Shahdadfar et al., 2005; Mannello and Tonti, 2007) . Concerning the use of blood-plasma supplemented media, two studies reported successful cultivation of MSCs in vitro (Lin et al., 2005; Vogel et al., 2006) . Remarkably, there are so far no such media available for human neural crest-derived stem cells. Moreover, even for hMSCs, no particularly blood-plasmabased stem cell media are actually used in clinical therapy (Tekkatte et al., 2011) . In contrast to blood serum, blood plasma contains fi brinogen and further clotting factors (reviewed in Currie et al., 2001) . Cultivation of ITSCs in human blood plasma supplemented medium led to formation of a 3D semi-solid fi brin matrix in vitro, resulting in a dense and biocompatible meshwork. Thus, we showed for the fi rst time the feasibility of a three-dimensional matrix for cultivation of human neural crest-derived stem cells. There are several possibilities to construct 3D matrices from synthetic materials such as nanofi bres made of poly-(-l-lactic acid) (Paletta et al., 2011) . They offer the advantage of the production of guided structures but must be electrospan. Remarkably, even in recently published tissue-engineering studies stem cells were still 2D-cultivated and needed to be given into artifi cial matrices before transplantation (Wang et al., 2011) . Here, we show a natural nanofi bre network formed by fi brin from blood plasma, which can be effi ciently used for culture of NCSCs. Nevertheless, a production of such guided structures for stem cell culture needs additional effort. However, taking into consideration the semi-solidity of the fi brin matrix, 3D-cultivated ITSCs may be transplanted minimallyinvasive by simple injection, facilitating their therapeutic use. Noteworthy, although a patent search using Espacenet (EPO) revealed patents for artificial 3D matrices for transplantation, no patents were found concerning the use of human blood plasma for 3D culture of stem cells.
It is noteworthy that beside the growth factors in human blood plasma, also the containing fi brinogen may be supportive for the survival of the stem cells. It has been recently described that senescent cultures of human dermal fi broblasts can re-enter the cell cycle if immobilised in an artifi cial fi brin polymer (Acevedo et al., 2009) . Moreover, fi brin polymers are already commonly used as grafts for transplantation, for they support cell survival, graft adherence, reduce bacterial infection and are biodegradable (Ronfard et al., 1991; Dahlstrom et al., 1992; Currie et al., 2001; Bensaid et al., 2003; Shaikh et al., 2008; Gerard et al., 2011) .
Conclusion
Taken together we showed that adult human neural crest-derived stem cells can be grown in a 3D blood plasma matrix resulting in increased proliferation, unchanged ploidy and capability for self-renewal as well as remaining potential to differentiate into neuronal and osteogenic lineage. Our fi ndings emphasise the potential of this cultivation method for cultivation of stem cells for complex regenerative approaches, like the treatment of musculoskeletal degeneration or craniofacial defects caused by accidents or cancer. Since ITSCs and human blood plasma can be obtained directly from the patient, this approach is personalisable and potentially reduces the exposure of the graft to xenogenic ingredients to a minimum.
As provided schematically in Fig. 9 , ITSCs may be isolated age-independent from a given patient, for instance after craniofacial injury or damage of the nervus facialis. Simultaneously to the ITSC isolation, autologous blood plasma can be taken from the same patient. Consequently, ITSCs might be expanded rapidly in an autologous 3D fi brin matrix in vitro. Since ITSCs are located in the fi brin matrix, cultivation may be followed directly by transplantation of the stem cell containing matrix into the patient. Here, the fi brin matrix may support graft adherence and reduce bacterial infection. Importantly, our method may be suitable for the animal-serum free cultivation of further human neural-crest derived stem cells, such as the newly described human epidermal stem cells (hEPINCSCs) (Clewes et al., 2011) or skin derived progenitors (SKPs) (Toma et al., 2001; Toma et al., 2005) .
